Kymera Therapeutics Depreciation & Amortization 2011-2026 | KYMR

Annual Depreciation & Amortization Kymera Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
8.31 M	7.37 M	3.56 M	2.98 M	2.4 M	1.76 M	825 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
8.31 M	825 K	3.89 M

Quarterly Depreciation & Amortization Kymera Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
2.1 M	1.7 M	2.05 M	-	2 M	1.9 M	1.46 M	-	900 K	900 K	879 K	-	800 K	700 K	687 K	-	1.71 M	1.04 M	485 K	-	1.27 M	776 K	387 K	-	464 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.1 M	387 K	1.17 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Autolus Therapeutics plc AUTL	8.3 M	$ 1.38	-1.08 %	$ 367 M	Britain
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
DBV Technologies S.A. DBVT	2.99 M	$ 20.52	0.79 %	$ 2.86 B	France
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Aytu BioScience AYTU	5.38 M	$ 2.57	-3.48 %	$ 16.1 M	USA
Forte Biosciences FBRX	64 K	$ 26.92	1.8 %	$ 349 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Fulcrum Therapeutics FULC	1.39 M	$ 7.72	-1.4 %	$ 489 K	USA
Galectin Therapeutics GALT	1 K	$ 2.24	-12.55 %	$ 143 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Gilead Sciences GILD	370 M	$ 138.79	-0.96 %	$ 173 B	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Galmed Pharmaceuticals Ltd. GLMD	42 K	$ 0.56	8.45 %	$ 521 K	Israel
Gossamer Bio GOSS	24 K	$ 0.32	-7.03 %	$ 73.1 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
GT Biopharma GTBP	4 K	$ 0.41	-7.26 %	$ 2.26 M	USA
Halozyme Therapeutics HALO	11.4 M	$ 63.49	0.64 %	$ 7.61 B	USA
Coherus BioSciences CHRS	1.3 M	$ 1.62	-3.1 %	$ 190 M	USA
Akari Therapeutics, Plc AKTX	14 K	$ 3.32	-6.21 %	$ 224 B	Britain
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Alnylam Pharmaceuticals ALNY	55.7 M	$ 318.56	-3.57 %	$ 41.7 B	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Harmony Biosciences Holdings HRMY	23.8 M	$ 27.62	-0.34 %	$ 1.59 B	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
iBio IBIO	484 K	$ 2.08	2.47 %	$ 21.8 M	USA
ImmuCell Corporation ICCC	2.78 M	$ 6.54	-1.06 %	$ 59 M	USA